Federated Hermes, Inc. Biote Corp. Transaction History

Federated Hermes, Inc.

$41.2 Billion
Q2 2024

A detailed history of Federated Hermes, Inc. transactions in Biote Corp. stock. As of the latest transaction made, Federated Hermes, Inc. holds 121 shares of BTMD stock, worth $630. This represents 0.0% of its overall portfolio holdings.

Number of Shares

121

Holding current value

$630

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 08, 2024	BUY	$5.44 - $7.47 $658 - $903	121 New	121 $0
Q2 2023 Aug 14, 2023	BUY	$5.27 - $6.9 $147 - $193	28 New	28 $0

Others Institutions Holding BTMD

# of Institutions

Shares Held

15.9M

Call Options Held

Put Options Held

325 Capital LLC New York, NY

3.77M
Shares

$19.6 Million
12.3% of portfolio
Bandera Partners LLC New York, NY

2.44M
Shares

$12.7 Million
6.61% of portfolio
Black Rock Inc. New York, NY

1.61M
Shares

$8.36 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.38M
Shares

$7.19 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

1.29M
Shares

$6.69 Million
0.05% of portfolio

View Full List

About biote Corp.

Ticker BTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 7,574,270
Market Cap $39.5M
Description
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...

More about BTMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account